Uncategorised - European Medical Journal

Prostate Cancer Screening

Earlier Screening May Reduce Metastatic Prostate Cancer

Earlier prostate cancer screening and lower baseline PSA levels were associated with markedly lower rates of metastatic prostate cancer among more than 103,000 veterans.

CAR T Cell Therapy Shows Promise for Myelofibrosis

Personalised CAR T cell therapy selectively eliminated mutant blood cancer cells in preclinical models of myelofibrosis while preserving healthy blood cells, supporting plans for first in human clinical evaluation.

blood plasma donation

MHRA Approves UK-Donor Plasma for High-Priority Medicines

The MHRA has approved the use of UK-donor plasma for five high-priority plasma-derived medicinal products.

Immunotherapy Super-Responders in Lung Cancer

Immune-checkpoint inhibitors (ICI) are an indispensable part of first-line treatment concepts for most patients with metastatic non-small…

Review of the American Society of Clinical Oncology (ASCO) Annual Meeting 2026

THE 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) returned to Chicago, Illinois, USA, from May 29–June 2…

Our Latest Oncology Journal

The latest edition of AMJ Oncology is now live, distilling high-impact insights and the biggest breakthroughs from ASCO 2026 – spanning…

HER2-Positive Early Breast Cancer: Key Updates from ASCO 2026

Updates on the evolving treatment landscape in HER2+ eBC presented at ASCO 2026, highlighting the role of trastuzumab deruxtecan…

Advancing Care in Metastatic Breast Cancer

The treatment landscape continues to evolve for patients with ER+/HER2– mBC. In this video, Seth Wander and Jennifer Caudle review two…

Hema Now: Inside Leukaemia Innovation

In this episode of Hema Now, Jorge Cortes reflects on the remarkable evolution of leukaemia treatment throughout his career, from the…

p53 Antibodies May Predict NSCLC Response

Cancer immunotherapy has transformed outcomes for patients with advanced non-small cell lung cancer (NSCLC), enabling long-term survival…